Reply to "Calibration technologies for correct determination of Epstein-Barr Virus, human herpesvirus 6 (HHV-6), and HHV-8 antiviral drug susceptibilities by use of real-time-PCR-based assays"

Comment

Lotfi Bounaadja et al. J Clin Microbiol. 2013 Jun.

. 2013 Jun;51(6):2014.

doi: 10.1128/JCM.00545-13.

No abstract available

Comment on

Evaluation of Epstein-Barr virus, human herpesvirus 6 (HHV-6), and HHV-8 antiviral drug susceptibilities by use of real-time-PCR-based assays.
Bounaadja L, Piret J, Goyette N, Boivin G. Bounaadja L, et al. J Clin Microbiol. 2013 Apr;51(4):1244-6. doi: 10.1128/JCM.03234-12. Epub 2013 Jan 16. J Clin Microbiol. 2013. PMID: 23325820 Free PMC article.
Calibration technologies for correct determination of Epstein-Barr Virus, human herpesvirus 6 (HHV-6), and HHV-8 antiviral drug susceptibilities by use of real-time-PCR-based assays.
Broccolo F, Lusso P, Malnati M. Broccolo F, et al. J Clin Microbiol. 2013 Jun;51(6):2013. doi: 10.1128/JCM.00504-13. J Clin Microbiol. 2013. PMID: 23682102 Free PMC article. No abstract available.

1. Zerr DM. 2006. Human herpesvirus 6: a clinical update. Herpes 13:20–24 - PubMed
1. Ensoli B, Sgadari C, Barillari G, Sirianni MC, Sturzl M, Monini P. 2001. Biology of Kaposi's sarcoma. Eur. J. Cancer 37:1251–1269 - PubMed
1. Macsween KF, Crawford DH. 2003. Epstein-Barr virus—recent advances. Lancet Infect. Dis. 3:131–140 - PubMed
1. Bounaadja L, Piret J, Goyette N, Boivin G. 2013. Evaluation of Epstein-Barr virus, human herpesvirus 6 (HHV-6), and HHV-8 antiviral drug susceptibilities by use of real-time-PCR-based assays. J. Clin. Microbiol. 51:1244–1246 - PMC - PubMed
1. Broccolo F, Lusso P, Malnati M. 2013. Calibration technologies for correct determination of Epstein-Barr virus, human herpesvirus 6 (HHV-6), and HHV-8 antiviral drug susceptibilities by use of real-time-PCR-based assays. J. Clin. Microbiol. 51:2013. - PMC - PubMed